Phase 1 Hyperinsulinism Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy

Breast CancerHER2-negative Breast CancerHyperinsulinism

Yale University20 enrolled1 locationNCT05989347

Recruiting

Phase 1

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Congenital HyperinsulinismInsulinoma

Cook Children's Health Care System250 enrolled1 locationNCT02021604